Skip to main content
. 2019 Sep 11;4(13):15560–15566. doi: 10.1021/acsomega.9b01920

Figure 3.

Figure 3

In vivo biodistribution of 18F-RWY in subcutaneous HT29 tumor-bearing mice. (A) A γ counter was used to quantify the 18F-RWY uptakes in tumor tissues and normal tissues and organs (n = 3). (B) Tumor-to-organ ratios of 18F-RWY at 60 min postinjection (n = 3).